BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative Employers
  Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our Industry eNewsletter FREE email:    
 Investor News
Clinical Development News
Pre-Clinical
IND
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
BLA/NDA/ANDA
PDUFA
Approvable Letters
Approval and Marketing Clearance
Post-Approval
Discontinued
Recalls and Warnings
Deals & Dollars News
Alliances
Earnings Reports
Financial
Investor
Mergers and Acquisitions 
Start-Ups
IPO News
IPO
 


Clinical - Pre-Clinical
Alnylam Pharmaceuticals (ALNY) Presents Key Pre-Clinical Proof-of-Concept Data for ALN-AS1, an RNAi Therapeutic Targeting Aminolevulinate Synthase-1 (ALAS-1) for the Treatment of Porphyria 5/17/2013 9:47:50 AM    More...
Merck & Co., Inc. (MRK), Bristol-Myers Squibb Company (BMY) and Roche (RHHBY)'s Human Immune-Boosting Cancer Drugs Seen Extending Lives 5/13/2013 7:59:31 AM    More...
Mesoblast Limited's Preclinical Trial Results of Intracoronary Cell Therapy Published in Circulation Research 5/15/2013 9:31:16 AM    More...
Senesco Technologies, Inc. (SNT) Announces Presentation on Combination Therapy With Novel Nanoparticle, SNS01-T, and Bortezomib Results in Synergistic Cytotoxicity In Vitro and In Vivo in Multiple Myeloma 5/14/2013 10:59:42 AM    More...
Starpharma Holdings Ltd's Dendrimer a Potential Viral Conjunctivitis Treatment 5/13/2013 9:56:13 AM    More...
SANUWAVE, Inc. Completes Investigator Meeting 5/13/2013 9:46:18 AM    More...
Pluristem Therapeutics (PSTI) Release: Preclinical Research Shows PLX Cells May be Effective in Treating Preeclampsia 5/13/2013 9:34:49 AM    More...
Acceleron Pharma’s ACE-536 Preclinical Data Presentation Selected for Best Abstract at 12th International Symposium on Myelodysplastic Syndromes 5/10/2013 11:28:40 AM    More...
Novavax, Inc. (NVAX) H7N9 VLP Influenza Vaccine Enters Animal Testing 5/10/2013 9:34:40 AM    More...
Precision Therapeutics, Inc. Presents Clinical Data Demonstrating Prediction for Platinum Resistance to First-Line Chemotherapy in Primary Ovarian Cancer at WAGO 5/9/2013 10:50:04 AM    More...
Acorda Therapeutics (ACOR) Announces Data Showing Dalfampridine Improves Motor Function in Preclinical Model of Post-Stroke Deficits Published in Stroke 5/9/2013 10:47:36 AM    More...
Differences Between "Marathon Mice" and "Couch Potato Mice" Reveal Key to Muscle Fitness, Sanford-Burnham Medical Research Institute Study 5/8/2013 10:52:12 AM    More...
Nuvilex Shows Success Treating Mammary Tumors Using Cell Encapsulation Technology 5/7/2013 10:55:56 AM    More...
Ablynx Starts Pre-Clinical Development of ALX-0962, an Anti-IgE Nanobody, to Treat Severe Allergic Asthma 5/7/2013 10:21:25 AM    More...
CEL-SCI (CVM) Presents Data Showing LEAPS Vaccine is Successful in Reducing Rheumatoid Arthritis Index Score in a Second Animal Model 5/6/2013 10:10:21 AM    More...
1234567